Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
帕博利珠单抗治疗非小细胞肺癌脑转移患者：一项非随机、开放标签的 II 期试验的长期结果和生物标志物分析
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(20)30111-X
Goldberg, Sarah B; Schalper, Kurt A; Gettinger, Scott N; Mahajan, Amit; Herbst, Roy S; Chiang, Anne C; Lilenbaum, Rogerio; Wilson, Frederick H; Omay, Sacit Bulent; Yu, James B; Jilaveanu, Lucia; Tran, Thuy; Pavlik, Kira; Rowen, Elin; Gerrish, Heather; Komlo, Annette; Gupta, Richa; Wyatt, Hailey; Ribeiro, Matthew; Kluger, Yuval; Zhou, Geyu; Wei, Wei; Chiang, Veronica L; Kluger, Harriet M
